Effect of Anapsos® in a murine model of experimental trichomoniasis

14Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Immunomodulator effect of Anapsos® (Polypodium leucotomos extract) in NMRI (US Naval Medical Research Institute) outbred mice infected by the intraperitoneal route with 107 Trichomonas vaginalis has been tested. Gross histopathologic changes in abdominal organs and mortality rate, as a consequence of the pathogenicity of the protozoa and the immune response of the host, were evaluated. Among the different treatment regimes assayed, Anapsos® at doses of 20 mg/Kg/day administered for 10 days before infection decreases the parasite pathogenicity index (PI) in the treated animals when compared to those of the untreated control group. The immunosuppresor treatments with azathioprine (100 mg/Kg/day x 1), cyclophosphamide (100 mg/Kg/day x 1), and FK-506 (10 mg/Kg/day x 10) significantly decreased the PI, while an immunostimulant treatment with glycophosphopeptical (13 mg/Kg/day x 10) increased it. These assays have shown the usefulness of the murine model of experimental trichomoniasis for the study of immunomodulator activity of natural or synthetic drugs.

Cite

CITATION STYLE

APA

Nogal-Ruiz, J. J., Gómez-Barrio, A., Escario, J. A., & Martínez-Fernández, A. R. (2003). Effect of Anapsos® in a murine model of experimental trichomoniasis. Parasite, 10(4), 303–308. https://doi.org/10.1051/parasite/2003104303

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free